Literature DB >> 28396344

Critical role for complement receptor C5aR2 in the pathogenesis of renal ischemia-reperfusion injury.

Felix Poppelaars1, Maaike B van Werkhoven1, Juha Kotimaa2, Zwanida J Veldhuis3, Albertina Ausema4, Stefan G M Broeren1, Jeffrey Damman5, Julia C Hempel1, Henri G D Leuvenink3, Mohamed R Daha1,2, Willem J van Son1, Cees van Kooten2, Ronald P van Os4, Jan-Luuk Hillebrands6, Marc A Seelen7.   

Abstract

The complement system, and specifically C5a, is involved in renal ischemia-reperfusion (IR) injury. The 2 receptors for complement anaphylatoxin C5a (C5aR1 and C5aR2) are expressed on leukocytes as well as on renal epithelium. Extensive evidence shows that C5aR1 inhibition protects kidneys from IR injury; however, the role of C5aR2 in IR injury is less clear as initial studies proposed the hypothesis that C5aR2 functions as a decoy receptor. By Using wild-type, C5aR1-/-, and C5aR2-/- mice in a model of renal IR injury, we found that a deficiency of either of these receptors protected mice from renal IR injury. Surprisingly, C5aR2-/- mice were most protected and had lower creatinine levels and reduced acute tubular necrosis. Next, an in vivo migration study demonstrated that leukocyte chemotaxis was unaffected in C5aR2-/- mice, whereas neutrophil activation was reduced by C5aR2 deficiency. To further investigate the contribution of renal cell-expressed C5aR2 vs leukocyte-expressed C5aR2 to renal IR injury, bone marrow chimeras were created. Our data show that both renal cell-expressed C5aR2 and leukocyte-expressed C5aR2 mediate IR-induced renal dysfunction. These studies reveal the importance of C5aR2 in renal IR injury. They further show that C5aR2 is a functional receptor, rather than a decoy receptor, and may provide a new target for intervention.-Poppelaars, F., van Werkhoven, M. B., Kotimaa, J., Veldhuis, Z. J., Ausema, A., Broeren, S. G. M., Damman, J., Hempel, J. C., Leuvenink, H. G. D., Daha, M. R., van Son, W. J., van Kooten, C., van Os, R. P., Hillebrands, J.-L., Seelen, M. A. Critical role for complement receptor C5aR2 in the pathogenesis of renal ischemia-reperfusion injury. © FASEB.

Entities:  

Keywords:  PMNs; innate immunity; kidney

Mesh:

Substances:

Year:  2017        PMID: 28396344     DOI: 10.1096/fj.201601218R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  15 in total

1.  T Cell Expression of C5a Receptor 2 Augments Murine Regulatory T Cell (TREG) Generation and TREG-Dependent Cardiac Allograft Survival.

Authors:  Divya A Verghese; Markus Demir; Nicholas Chun; Miguel Fribourg; Paolo Cravedi; Ines Llaudo; Trent M Woodruff; Pragya Yadav; Sergio A Lira; M Edward Medof; Peter S Heeger
Journal:  J Immunol       Date:  2018-02-07       Impact factor: 5.422

Review 2.  The complex functioning of the complement system in xenotransplantation.

Authors:  Hongmin Zhou; Hidetaka Hara; David K C Cooper
Journal:  Xenotransplantation       Date:  2019-04-29       Impact factor: 3.907

3.  The Second Receptor for C5a, C5aR2, Is Detrimental to Mice during Systemic Infection with Listeria monocytogenes.

Authors:  Stacey L Mueller-Ortiz; Pooja Shivshankar; Rick A Wetsel
Journal:  J Immunol       Date:  2019-10-09       Impact factor: 5.422

4.  C3 Drives Inflammatory Skin Carcinogenesis Independently of C5.

Authors:  William D Jackson; Alessandro Gulino; Liliane Fossati-Jimack; Rocio Castro Seoane; Kunyuan Tian; Katie Best; Jörg Köhl; Beatrice Belmonte; Jessica Strid; Marina Botto
Journal:  J Invest Dermatol       Date:  2020-07-16       Impact factor: 8.551

Review 5.  The Complement System in Dialysis: A Forgotten Story?

Authors:  Felix Poppelaars; Bernardo Faria; Mariana Gaya da Costa; Casper F M Franssen; Willem J van Son; Stefan P Berger; Mohamed R Daha; Marc A Seelen
Journal:  Front Immunol       Date:  2018-01-25       Impact factor: 7.561

Review 6.  The Controversial C5a Receptor C5aR2: Its Role in Health and Disease.

Authors:  Ting Zhang; Malgorzata A Garstka; Ke Li
Journal:  J Immunol Res       Date:  2017-06-15       Impact factor: 4.818

7.  Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.

Authors:  Caroline S Colley; Bojana Popovic; Sudharsan Sridharan; Judit E Debreczeni; David Hargeaves; Michael Fung; Ling-Ling An; Bryan Edwards; Joanne Arnold; Elizabeth England; Laura Eghobamien; Ulf Sivars; Liz Flavell; Jonathan Renshaw; Kate Wickson; Paul Warrener; Jingying Zha; Jessica Bonnell; Rob Woods; Trevor Wilkinson; Claire Dobson; Tristan J Vaughan
Journal:  MAbs       Date:  2017-10-24       Impact factor: 5.857

8.  Complement Activation During Ischemia/Reperfusion Injury Induces Pericyte-to-Myofibroblast Transdifferentiation Regulating Peritubular Capillary Lumen Reduction Through pERK Signaling.

Authors:  Giuseppe Castellano; Rossana Franzin; Alessandra Stasi; Chiara Divella; Fabio Sallustio; Paola Pontrelli; Giuseppe Lucarelli; Michele Battaglia; Francesco Staffieri; Antonio Crovace; Giovanni Stallone; Marc Seelen; Mohamed R Daha; Giuseppe Grandaliano; Loreto Gesualdo
Journal:  Front Immunol       Date:  2018-05-23       Impact factor: 7.561

9.  The C5a/C5aR2 axis promotes renal inflammation and tissue damage.

Authors:  Ting Zhang; Kun-Yi Wu; Ning Ma; Ling-Lin Wei; Malgorzata Garstka; Wuding Zhou; Ke Li
Journal:  JCI Insight       Date:  2020-04-09

10.  Role of C5aR1 and C5L2 Receptors in Ischemia-Reperfusion Injury.

Authors:  Carlos Arias-Cabrales; Eva Rodriguez-Garcia; Javier Gimeno; David Benito; María José Pérez-Sáez; Dolores Redondo-Pachón; Anna Buxeda; Carla Burballa; Marta Crespo; Marta Riera; Julio Pascual
Journal:  J Clin Med       Date:  2021-03-02       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.